共 50 条
- [21] Utility of single-pill amlodipine besylate/atorvastatin calcium to help Asian patients with hypertension and dyslipidemia achieve blood pressure and lipid goals: Results of a pooled analysisINTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 58 - 58Tse, Hung F.Blank, RoyVictor, RonaldHobbs, RichardShi, HarryMoller, Robert A.Schou, Ishani M.Gensini, GianfrancoChopra, Pravin
- [22] A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE StudyJOURNAL OF CLINICAL MEDICINE, 2022, 11 (02)Jo, Sang-HoKang, Seok MinYoo, Byung SuLee, Young SooYoun, Ho JoongMin, KyungwanYu, Jae MyungYoon, Hyun JuKim, Woo ShikKim, Gee HeePark, Jae HyoungKim, Seok YeonKim, Cheol Ho
- [23] Safety and Tolerability of Cyclosporin A in Severe Traumatic Brain Injury Patients: Results from a Prospective Randomized TrialJOURNAL OF NEUROTRAUMA, 2009, 26 (12) : 2195 - 2206Mazzeo, Anna TeresaBrophy, Gretchen M.Gilman, Charlotte B.Alves, Oscar LuisRobles, Jaime R.Hayes, Ronald L.Povlishock, John T.Bullock, M. Ross
- [24] A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and DyslipidemiaAMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (4) : 441 - 454Kim, Min ChulAhn, YoungkeunKim, Moo HyunKim, Seok-YeonHong, Taek JongRhee, Moo-YongKim, Sang-HyunHong, Soon-JunKim, HyungseopKim, WeonChae, In HoKang, Duk-hyunKim, Byeong-KeukKim, Hyo-Soo
- [25] A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and DyslipidemiaAmerican Journal of Cardiovascular Drugs, 2023, 23 : 441 - 454Min Chul KimYoungkeun AhnMoo Hyun KimSeok-Yeon KimTaek Jong HongMoo-Yong RheeSang-Hyun KimSoon-Jun HongHyungseop KimWeon KimIn Ho ChaeDuk-hyun KangByeong-Keuk KimHyo-Soo Kim
- [26] Safety and tolerability profile of lumateperone (ITI-007): Results from a phase 3 clinical trial for the treatment of bipolar depressionBIPOLAR DISORDERS, 2020, 22 : 83 - 83Yatham, LakshmiDurgam, SureshSatlin, AndrewVanover, Kimberly E.Davis, Robert E.Kozauer, Susan G.Huo, JasonMates, Sharon
- [27] Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignanciesLEUKEMIA & LYMPHOMA, 2024, 65 (04) : 503 - 510Stein, Eytan M.Fathi, Amir T.Harb, Wael A.Colak, GozdeFusco, AndreaMangan, James K.
- [28] Efficacy and Safety of Coadministered Ezetimibe-Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III TrialJOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)Song, Zhao-YanKim, Moo-HyunLee, Han-CheolPark, Sung-JiRhee, Moo-YongChoi, Jong-IlKim, Sang-HyunChae, In-HoHong, Young-JoonLee, Nam-HoHwang, Gyo-SeungHur, Seung-HoSon, Jung-WooChae, Jei-KeonKim, Hyo-Soo
- [29] Ustekinumab shows favourable safety profile and drug persistence rates in patients with Crohn's Disease - results from a tertiary IBD centreJOURNAL OF CROHNS & COLITIS, 2024, 18 : I1072 - I1072不详
- [30] A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapyCLINICAL HYPERTENSION, 2022, 28 (01)Jeon, Eun-SeokLim, Sang WookKim, Seok-YeonYang, Hyoung-MoKim, Moo HyunRhee, Moo-YongHan, Seung HwanShin, JinhoKim, Kwang-ilJeong, Jin-OkSung, Ki ChulHong, Geu RuKim, Hyung-SeopKwon, KihwanKang, Tae-SooLee, Hae-YoungHan, Su-Eun